ICU Medical, Inc.
General ticker "ICUI" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $3.3B (TTM average)
ICU Medical, Inc. follows the US Stock Market performance with the rate: 36.5%.
Estimated limits based on current volatility of 1.8%: low 155.78$, high 161.47$
Factors to consider:
- Total employees count: 13000 (-13.3%) as of 2025
- US accounted for 64.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Product development failure, Regulatory and compliance, Supply chain disruptions, Economic downturns and volatility
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [105.73$, 162.24$]
- 2026-12-31 to 2027-12-31 estimated range: [100.89$, 157.07$]
Financial Metrics affecting the ICUI estimates:
- Negative: with PPE of 18.9 at the end of fiscal year the price was very high
- Positive: -5.34 < Operating profit margin, % of 1.92
- Positive: Investing cash flow per share per price, % of 3.39 > -0.60
- Positive: 42.57 < Shareholder equity ratio, % of 52.43 <= 64.23
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.67
Short-term ICUI quotes
Long-term ICUI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,259.13MM | $2,382.05MM | $2,231.26MM |
| Operating Expenses | $2,236.30MM | $2,339.08MM | $2,188.43MM |
| Operating Income | $22.82MM | $42.96MM | $42.83MM |
| Non-Operating Income | $-101.12MM | $-108.98MM | $-38.47MM |
| Interest Expense | $95.22MM | $95.75MM | $83.03MM |
| R&D Expense | $85.34MM | $88.61MM | $87.50MM |
| Income(Loss) | $-78.30MM | $-66.01MM | $4.36MM |
| Taxes | $-48.64MM | $51.68MM | $2.44MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $-1.19MM |
| Net Income(Loss)* | $-29.66MM | $-117.69MM | $0.73MM |
| Stockholders Equity | $2,123.41MM | $1,965.23MM | $2,123.82MM |
| Inventory | $709.36MM | $584.68MM | $615.86MM |
| Assets | $4,378.44MM | $4,203.93MM | $4,050.51MM |
| Operating Cash Flow | $166.20MM | $204.03MM | $179.85MM |
| Capital expenditure | $93.67MM | $79.37MM | $88.04MM |
| Investing Cash Flow | $-87.95MM | $-88.96MM | $122.23MM |
| Financing Cash Flow | $-35.98MM | $-55.80MM | $-311.52MM |
| Earnings Per Share** | $-1.23 | $-4.83 | $0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.